Methyl 5-formyl-4-methyl-1H-pyrrole-2-carboxylate → 4-Methyl-5-(2-oxo-1,2-dihydroindol-3-ylidenemethyl)-1H-pyrrole-2-carboxylic acid methyl ester
반응식
[O:1]=[C:2]1[CH:10]=[C:9]2[C:4]([CH:5]=[CH:6][CH:7]=[CH:8]2)=[N:3]1.[CH3:11][O:12][C:13]([C:15]1[NH:16][C:17]([CH:21]=O)=[C:18]([CH3:20])[CH:19]=1)=[O:14]>>[CH3:11][O:12][C:13]([C:15]1[NH:16][C:17]([CH:21]=[C:10]2[C:9]3[C:4](=[CH:5][CH:6]=[CH:7][CH:8]=3)[NH:3][C:2]2=[O:1])=[C:18]([CH3:20])[CH:19]=1)=[O:14]참가 물질
3
실험 절차
Oxoindole (105 mg, 0.79 mmol) was condensed with 5-formyl-4-methyl-1H-pyrrole-2-carboxylic acid methyl ester (110 mg, 0.67 mmol) using method E to give 153.2 mg (81%) of the title compound.
출처 및 근거
- ORD 기록
- ord-7935f83ca24748c0b9ace0c6a989c9ce
- 출처 데이터셋
- uspto-grants-2005_04
- 특허 번호
- US06878733B1
반응 노트
불러오는 중…